Apotex Health Corp's stock has seen a slight decline in today's trading despite a positive weekly performance.
As of today's trading session, Apotex Health Corp (APTX.TO) is down 0.32% to close at C$38.05. Over the past week, the stock has gained 2.13%, contributing to a year-to-date increase of 35.93%. Investors are closely monitoring the company following a series of strategic moves and market developments.
Investor takeaway: While Apotex Health Corp has recently made headlines with its strategic transactions and credit agreements, the stock's current price action suggests a cautious sentiment among investors. It's essential to consider the technical indicators and market performance as you evaluate your investment decisions.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeAdvertisement
Market cap
$8.66B
P/E
22.8x
52W high
$40.18
52W low
$26.05
1W change
+2.13%
Analyst Price Targets
Based on analyst covering APTX
Wall Street analysts forecast APTX stock price to rise 10.3% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.24
+10.3% Upside
Current Price
C$37.38
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
54.8%
Annualized
90-Day Vol
52.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$44.69
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$39.67 | C$32.84 – C$47.93 |
| 60 trading days | C$42.11 | C$32.23 – C$55.01 |
| 90 trading days | C$44.69 | C$32.21 – C$61.99 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
C$38.05 closing price
With a P/E ratio of 22.79 and a profit margin of 10.7%, Apotex Health Corp is positioned for moderate growth, but investor sentiment appears mixed.
Bull case
The recent investment-grade issuer rating and successful credit agreement put Apotex Health Corp in a good position for future growth, especially as it integrates Cumberland Pharmaceuticals' U.S. businesses.
Bear case
Despite these positive developments, the stock has shown some volatility. Current trading volume is significantly below the 20-day average, indicating that investors may be cautious.
Weekly Performance Overview
Apotex Health Corp's stock closed at C$38.05 today, reflecting a slight decrease of 0.32%. However, the stock has shown resilience over the past week, gaining 2.13%. Year-to-date, APTX.TO has experienced a remarkable increase of 35.93%, indicating strong investor interest since its recent market activities.
Advertisement
Recent Company Developments
In recent weeks, Apotex Health Corp has been active in the market, announcing several strategic moves. Notably, the company received an investment-grade issuer rating and completed an amended credit agreement, which could enhance its financial flexibility. Additionally, the integration of Cumberland Pharmaceuticals' U.S. branded businesses signifies a significant step in expanding its market presence.
Technical Picture
From a technical perspective, APTX.TO is trading well above its 50-day and 200-day moving averages of C$34.32, which are both 10.9% lower than the current price. The stock's 52-week range has been between C$26.05 and C$40.18, indicating that it is currently trading at approximately 85% of its range. The recent trading volume of 102,871 shares is notably lower than the 20-day average volume of 404,702 shares, suggesting a potential decrease in trading activity.
Investor Sentiment and Outlook
The average analyst target for APTX.TO is C$41.24, implying a potential upside of approximately 8.4% from the current price. The outlook remains moderately bullish, but the current trading volume and slight decline today may reflect some investor caution as they assess the implications of the recent company developments.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
